Plant-derived phytosterols — β-sitosterol, stigmasterol, and fucosterol — as cholesterol substitutes in mRNA-LNPs improve transfection efficiency and lyophilization stability. This 2026 Materials Today Bio study demonstrates functional restoration of vision in RCS rats via MERTK mRNA gene therapy, with LNPs formulated using the PreciGenome NanoGenerator®.

Radiation-induced liver damage (RILD) is a severe and dose-limiting complication of radiotherapy for abdominal and thoracic malignancies. The pathogenesis of RILD involves a complex inflammatory response largely driven by Kupffer cells (KCs), which are the liver's resident macrophages. Upon exposure to ionizing radiation, these cells rapidly activate and secrete pro-inflammatory cytokines. This process exacerbates tissue injury and promotes structural damage. However, the exa

Radiation-attenuated sporozoite (RAS) vaccination is considered the gold standard for liver-stage malaria immunity, capable of inducing up to The 5′-cap is an essential structural element at the terminus of eukaryotic mRNA that drives translation initiation by recruiting the eukaryotic initiation factor 4F (eIF4F) complex. In therapeutic mRNA, the identity and chemistry of this cap structure directly govern capping efficiency, translational output, protein yield, and mRNA sta

Radiation-attenuated sporozoite (RAS) vaccination is considered the gold standard for liver-stage malaria immunity, capable of inducing up to 100% sterilizing protection in naïve hosts through CD8⁺ T cell–mediated mechanisms. These include circulating effector memory (T~EM~) and liver-resident memory (T~RM~) responses. Critically however, RAS efficacy drops to 30–50% in field trials conducted in malaria-endemic regions, and mechanisms underlying this failure in previously exp

Radiation-attenuated sporozoite (RAS) vaccination is considered the gold standard for liver-stage malaria immunity, capable of inducing up to 100% sterilizing protection in naïve hosts through CD8⁺ T cell–mediated mechanisms. These include circulating effector memory (T~EM~) and liver-resident memory (T~RM~) responses. Critically however, RAS efficacy drops to 30–50% in field trials conducted in malaria-endemic regions, and mechanisms underlying this failure in previously exp

This research addresses a critical gap in understanding how RNA-binding proteins (RBPs) contribute to osteoarthritis pathogenesis and explores the therapeutic potential of protein replacement therapy using innovative circular RNA delivery systems. This offers new perspectives on treating degenerative joint diseases through precision molecular interventions.

African swine fever virus (ASFV) is a large, structurally complex double-stranded DNA virus with a 180–190 kbp genome encoding over 150 genes. It causes African swine fever (ASF) with mortality rates reaching 90–100% and has become a major threat to global pig production. The virus spread from sub-Saharan Africa to Eurasia after 2007 and was detected in the Dominican Republic and Haiti in 2021, marking the emergence of the Eurasian pandemic genotype in the Western Hemisphere.

Feline coronaviruses (FCoVs) exist primarily as two serotypes: Serotype-1 (FCoV1) and Serotype-2 (FCoV2). FCoV1 is more prevalent but difficult to culture than FCoV2, though both can mutate into the lethal Feline Infectious Peritonitis Virus (FIPV). The study addresses the lack of effective vaccines that cross-protect against FCoV1, as current commercial options are based on the easier to culture FCoV2. By leveraging comparative virology, the authors explore a "minimized" pan

This research falls under the broader scientific discipline of molecular biology and cancer therapeutics, specifically within RNA-guided genome editing and precision oncology. CRISPR-Cas13d systems represent a powerful class of RNA-targeting tools that can precisely edit target transcripts with minimal off-target effects. However, their clinical development faces significant challenges. One of these is the limited biostability of conventional linear guide RNAs (lgRNAs) suscep

This research falls under the broader scientific discipline of molecular biology and cancer therapeutics, specifically within RNA-guided genome editing and precision oncology. CRISPR-Cas13d systems represent a powerful class of RNA-targeting tools that can precisely edit target transcripts with minimal off-target effects. However, their clinical development faces significant challenges. One of these is the limited biostability of conventional linear guide RNAs (lgRNAs) suscep

This research falls under the broader scientific discipline of molecular biology and cancer therapeutics, specifically within RNA-guided genome editing and precision oncology. CRISPR-Cas13d systems represent a powerful class of RNA-targeting tools that can precisely edit target transcripts with minimal off-target effects. However, their clinical development faces significant challenges. One of these is the limited biostability of conventional linear guide RNAs (lgRNAs) suscep

Hepatocellular carcinoma (HCC) represents the second leading cause of cancer-related mortality worldwide, claiming over 700,000 lives annually. The liver's central role in blood filtration and metabolism makes it an attractive target for drug delivery, with lipid nanoparticles (LNPs) showing particular promise due to their natural hepatic tropism. However, LNP efficacy becomes compromised in HCC environments due to inadequate understanding of liver physiology under cancerous

Maternally derived antibodies serve as crucial early-life protection for piglets against infectious diseases, including swine influenza A virus (SwIAV). However, these same protective antibodies create significant challenges for vaccination programs by interfering with vaccine-induced immune responses, thereby reducing vaccine effectiveness. This interference has been well-documented with whole inactivated virus (WIV) vaccines against SwIAV, creating an urgent need for innova

This research falls under the broader scientific discipline of molecular biology and cancer therapeutics, specifically within RNA-guided genome editing and precision oncology. CRISPR-Cas13d systems represent a powerful class of RNA-targeting tools that can precisely edit target transcripts with minimal off-target effects. However, their clinical development faces significant challenges. One of these is the limited biostability of conventional linear guide RNAs (lgRNAs) suscep

This research falls under the broader scientific discipline of molecular biology and cancer therapeutics, specifically within RNA-guided genome editing and precision oncology. CRISPR-Cas13d systems represent a powerful class of RNA-targeting tools that can precisely edit target transcripts with minimal off-target effects. However, their clinical development faces significant challenges. One of these is the limited biostability of conventional linear guide RNAs (lgRNAs) suscep

Nagoya University: New cyclic disulfide lipids deliver mRNA five times more effectively for cancer treatment University of Ottawa: Development of nano-sized delivery agents with therapeutic potential beyond messenger function University of Pennsylvania: Chemical modification of ionizable lipids reduces inflammation and boosts mRNA therapeutic effectiveness Academic Journals: Multiple publications on circular guide RNA engineering, CRISPR-Cas13d systems, and advanced LNP ch

This research falls within the rapidly evolving field of cancer immunotherapy and nanomedicine, specifically focusing on cytokine-based therapeutic approaches. The study addresses a critical challenge in IL-12 cytokine therapy - the immunosuppressive feedback mechanisms that limit its therapeutic efficacy1. IL-12 has demonstrated potent antitumor activity in preclinical models by promoting T helper type 1 (TH1) differentiation and enhancing cytotoxic T lymphocyte activity. Ho

Schematic to explain a dual nanocarrier strategy for enhancing PDAC Tumor Immunity. The schematic illustrates a dual vaccination strategy, hypothesized to enhance the PDAC tumor immunity cycle by integrating endogenous and exogenous vaccination approaches. This strategy employs two distinct nanocarriers to synergistically reinforce CTL activation against PDAC. Endogenous Vaccination: Chemotherapeutic agents such as irinotecan induce ICD, triggering the release of tumor antige

We're proud to share that the Mayo Clinic Florida’s new RNA Research Facility has chosen the PreciGenome NanoGenerator™ Flex-S as their...

Efficient and precise delivery of CRISPR/Cas9 components remains one of the critical challenges toward the advancement of gene-editing therapies. Here, we have developed a high-throughput Barcode-Integration Nanoparticle Screen (BINS) method to evaluate a library of 96 lipid nanoparticles (LNPs) for their delivery efficiency across  in vitro  and  in vivo  models.